Valneva to participate in goldman sachs eleventh annual biotech symposium

Saint- herb lain (france) , september 1 , 2 021 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today announced that its senior management will participate in 1-on-1 meetings with institutional investors at the goldman sachs eleventh annual biotech symposium on september 7, 2021.
VALN Ratings Summary
VALN Quant Ranking